Literature DB >> 21415290

Re-evaluation of pathogens causing Valsa canker on apple in China.

Xuli Wang1, Jieling Wei, Lili Huang, Zhensheng Kang.   

Abstract

Valsa canker is a destructive disease on apple that causes serious economic losses in eastern Asia. In the present study fungal isolates from cankered apple and pear bark were examined and compared with morphology and rDNA-ITS sequences. Valsa mali was confirmed to be an independent species and a causal pathogen of Valsa canker on apple and pear in China. It was the predominant species (96.7% of isolates) on apple and was complemented by V. malicola (3.3% of isolates). Significant intraspecific genetic differentiation was detected in V. mali with two varieties recognized, V. mali var. mali occurring exclusively on apple and V. mali var. pyri occurring on both apple and pear. Results from genetic analysis and cross-inoculation tests provided support for the hypothesis that host preference probably catalyzed such genetic changes within the pathogen populations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21415290     DOI: 10.3852/09-165

Source DB:  PubMed          Journal:  Mycologia        ISSN: 0027-5514            Impact factor:   2.696


  21 in total

1.  Purification and characterization of a potential antifungal protein from Bacillus subtilis E1R-J against Valsa mali.

Authors:  N N Wang; X Yan; X N Gao; H J Niu; Z S Kang; L L Huang
Journal:  World J Microbiol Biotechnol       Date:  2016-02-29       Impact factor: 3.312

2.  Agrobacterium tumefaciens-mediated transformation of the causative agent of Valsa canker of apple tree Valsa mali var. mali.

Authors:  Yang Hu; Qingqing Dai; Yangyang Liu; Zhe Yang; Na Song; Xiaoning Gao; Ralf Thomas Voegele; Zhensheng Kang; Lili Huang
Journal:  Curr Microbiol       Date:  2014-02-20       Impact factor: 2.188

3.  Validation of reference genes for gene expression analysis in Valsa mali var. mali using real-time quantitative PCR.

Authors:  Zhiyuan Yin; Xiwang Ke; Dingxuan Huang; Xiaoning Gao; Ralf T Voegele; Zhensheng Kang; Lili Huang
Journal:  World J Microbiol Biotechnol       Date:  2013-03-19       Impact factor: 3.312

Review 4.  Cryobiotechnology of apple (Malus spp.): development, progress and future prospects.

Authors:  Min-Rui Wang; Long Chen; Jaime A Teixeira da Silva; Gayle M Volk; Qiao-Chun Wang
Journal:  Plant Cell Rep       Date:  2018-01-11       Impact factor: 4.570

5.  The apple FERONIA receptor-like kinase MdMRLK2 negatively regulates Valsa canker resistance by suppressing defence responses and hypersensitive reaction.

Authors:  Yuanyuan Jing; Minghui Zhan; Chunrong Li; Tingting Pei; Qi Wang; Pengmin Li; Fengwang Ma; Changhai Liu
Journal:  Mol Plant Pathol       Date:  2022-04-12       Impact factor: 5.520

6.  Agrobacterium tumefaciens-mediated transformation of Valsa mali: an efficient tool for random insertion mutagenesis.

Authors:  Caixia Wang; Xiangnan Guan; Hanyan Wang; Guifang Li; Xiangli Dong; Guoping Wang; Baohua Li
Journal:  ScientificWorldJournal       Date:  2013-12-04

7.  Unconventional Recombination in the Mating Type Locus of Heterothallic Apple Canker Pathogen Valsa mali.

Authors:  Zhiyuan Yin; Xiwang Ke; Zhengpeng Li; Jiliang Chen; Xiaoning Gao; Lili Huang
Journal:  G3 (Bethesda)       Date:  2017-04-03       Impact factor: 3.154

8.  Candidate effector proteins of the necrotrophic apple canker pathogen Valsa mali can suppress BAX-induced PCD.

Authors:  Zhengpeng Li; Zhiyuan Yin; Yanyun Fan; Ming Xu; Zhensheng Kang; Lili Huang
Journal:  Front Plant Sci       Date:  2015-07-27       Impact factor: 5.753

9.  Toxins produced by Valsa mali var. mali and their relationship with pathogenicity.

Authors:  Caixia Wang; Chao Li; Baohua Li; Guifang Li; Xiangli Dong; Guoping Wang; Qingming Zhang
Journal:  Toxins (Basel)       Date:  2014-03-21       Impact factor: 4.546

10.  Delimiting cryptic pathogen species causing apple Valsa canker with multilocus data.

Authors:  Xuli Wang; Rui Zang; Zhiyuan Yin; Zhensheng Kang; Lili Huang
Journal:  Ecol Evol       Date:  2014-03-19       Impact factor: 2.912

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.